Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Toning down cancer’s aggressiveness

Prof. Mansoor Amiji is working on research that would battle cancer by making tumor cells less aggressive. Photo by Lauren McFalls.
Prof. Mansoor Amiji is working on research that would battle cancer by making tumor cells less aggressive. Photo by Lauren McFalls.

Abstract:
The researchers are working on using nanoparticles, engineered for drug delivery, to reverse the tumor cell clusters' resistance to anti-cancer therapies.

Toning down cancer’s aggressiveness

Boston, MA | Posted on November 3rd, 2010

The fight against some cancers could depend on using nanotechnology to trick tumor cells into feeling well fed.

Mansoor Amiji, Distinguished Professor of Pharmaceutical Sciences at Northeastern University, believes tumor cells—like people—become more aggressive in pursuit of nourishment when they're "hungry." He theorizes that clusters of cancer cells deep within a tumor, where they receive limited oxygen and other nutrients, have higher stress levels and are more aggressive in fighting off chemotherapy.

Working from this theory, Amiji, who chairs the Department of Pharmaceutical Sciences in the School of Pharmacy within the Bouvé College of Health Sciences, will collaborate with researchers at Northeastern and Massachusetts General Hospital to explore innovative drug delivery and gene-silencing strategies to target these cancers. Assistant Professor of Chemical Engineering Rebecca Carrier and Matthews Distinguished University Professor of Chemistry and Chemical Biology Robert Hanson are Amiji's Northeastern collaborators.

The researchers are working on using nanoparticles, engineered for drug delivery, to reverse the tumor cell clusters' resistance to anti-cancer therapies. The nanoparticles would permeate the parts of tumors where the aggressive cells live, carrying RNA molecules that would block messages from disease-causing genes. Cutting off that communication would prevent the tumor cells from developing certain proteins that make them aggressive.

Amiji predicts suppressing their aggression—or "hunger"—could be a major breakthrough in treating highly aggressive ovarian and lung cancers.

"When living in this (hostile) environment, the threshold for killing tumor cells is much higher," Amiji said. "We want the threshold to be minimal so low doses of chemotherapy will kill those cells and make the treatment safer."

Relapse is common for ovarian and lung cancers, and drugs used in the first round of treatment often become ineffective in future treatments, Amiji explained. As a result, a doctor's primary recourse is to create cocktails of multiple drugs and increase the dosages. But Amiji hopes his new approach can replace this current treatment method.

Amiji's project, which advances Northeastern's leadership in use-inspired, interdisciplinary health research, is funded by a five-year, $2.32 million Cancer Nanotechnology Platform Partnership grant from the National Cancer Institute's (NCI) Alliance for Nanotechnology in Cancer program. Through this grant, Amiji and his team will also develop a library of target-specific nanoparticles they can screen and select from on a case-by-case basis when treating various forms of cancer.

Amiji pointed to Northeastern's tremendous momentum in nanotechnology research. The NCI recently designated Northeastern a Center of Cancer Nanotechnology Excellence with a $13.5 million award. Northeastern's Integrative Graduate Education and Research Traineeship (IGERT) nanomedicine program recently received a $3.1 million grant from the National Science Foundation to continue its success in educating the next generation of scientists and technologists in nanomedicine.

The University also signed an agreement in September with federal health researchers to advance research and guidance for occupational safety and health in nanotechnology.

"We have created a coherent nucleus of research and education in translational nanomedicine at Northeastern," Amiji said.

####

Contacts:
Greg St.Martin
617-373-5463

Copyright © Northeastern University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Self-assembling 3D battery would charge in seconds May 22nd, 2018

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Disability Can Be a Superpower in Space Disabled astronauts offer unique solutions to emergencies in space May 17th, 2018

Possible Futures

Self-assembling 3D battery would charge in seconds May 22nd, 2018

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Disability Can Be a Superpower in Space Disabled astronauts offer unique solutions to emergencies in space May 17th, 2018

Academic/Education

Grand Opening of UC Irvine Materials Research Institute (IMRI) to Spotlight JEOL Center for Nanoscale Solutions: Renowned Materials Scientists to Present at the 1st International Symposium on Advanced Microscopy and Spectroscopy (ISAMS) April 18th, 2018

Lifeboat Foundation funds flying 3D-printed classroom cubesats with Perlan II April 16th, 2018

SUNY Poly’s Center for Semiconductor Research in Albany Earns World-Class TÜV SÜD AMERICA INC. ISO 9001:2015 Certification: Albany NanoTech Complex Certification Assures Top-Tier Quality in Semiconductor Test Structures; Certification a First for a SUNY Campus March 6th, 2018

Luleå University of Technology is using the Deben CT5000TEC stage to perform x-ray microtomography experiments with the ZEISS Xradia 510 Versa to understand deformation and strain inside inhomogeneous materials November 7th, 2017

Nanomedicine

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Elastic microspheres expand understanding of embryonic development and cancer cells May 15th, 2018

Nanomedicine -- Targeting cancer cells with sugars May 14th, 2018

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing: Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies May 9th, 2018

Announcements

Self-assembling 3D battery would charge in seconds May 22nd, 2018

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Disability Can Be a Superpower in Space Disabled astronauts offer unique solutions to emergencies in space May 17th, 2018

Nanobiotechnology

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Nanomedicine -- Targeting cancer cells with sugars May 14th, 2018

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing: Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies May 9th, 2018

Nanoscale measurements 100x more precise, thanks to improved two-photon technique May 8th, 2018

Research partnerships

Deeper understanding of quantum chaos may be the key to quantum computers May 16th, 2018

Nanoscale measurements 100x more precise, thanks to improved two-photon technique May 8th, 2018

Hematene joins parade of new 2D materials: Rice University-led team extracts 3-atom-thick sheets from common iron oxide May 8th, 2018

Nanobiotix and Weill Cornell Medicine Partner on Pre-Clinical Research Inbox x May 3rd, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project